GBA
Garrison Bradford & Associates’s Acadia Pharmaceuticals ACAD Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q2 | – | Sell |
-8,800
| Closed | -$227K | – | 53 |
|
2021
Q1 | $227K | Hold |
8,800
| – | – | 0.25% | 46 |
|
2020
Q4 | $470K | Buy |
8,800
+2,979
| +51% | +$159K | 0.57% | 33 |
|
2020
Q3 | $240K | Sell |
5,821
-100
| -2% | -$4.12K | 0.34% | 41 |
|
2020
Q2 | $287K | Hold |
5,921
| – | – | 0.42% | 35 |
|
2020
Q1 | $250K | Sell |
5,921
-600
| -9% | -$25.3K | 0.43% | 34 |
|
2019
Q4 | $279K | Buy |
6,521
+621
| +11% | +$26.6K | 0.35% | 39 |
|
2019
Q3 | $212K | Sell |
5,900
-22,800
| -79% | -$819K | 0.29% | 46 |
|
2019
Q2 | $767K | Sell |
28,700
-3,000
| -9% | -$80.2K | 0.9% | 27 |
|
2019
Q1 | $851K | Sell |
31,700
-1,000
| -3% | -$26.8K | 0.72% | 30 |
|
2018
Q4 | $529K | Sell |
32,700
-15,800
| -33% | -$256K | 0.48% | 37 |
|
2018
Q3 | $1.01M | Sell |
48,500
-5,000
| -9% | -$104K | 0.81% | 23 |
|
2018
Q2 | $817K | Sell |
53,500
-15,500
| -22% | -$237K | 0.67% | 27 |
|
2018
Q1 | $1.55M | Sell |
69,000
-5,150
| -7% | -$116K | 1.32% | 17 |
|
2017
Q4 | $2.23M | Buy |
74,150
+800
| +1% | +$24.1K | 1.85% | 14 |
|
2017
Q3 | $2.76M | Sell |
73,350
-500
| -0.7% | -$18.8K | 2.31% | 12 |
|
2017
Q2 | $2.06M | Buy |
73,850
+1,300
| +2% | +$36.3K | 1.78% | 14 |
|
2017
Q1 | $2.49M | Hold |
72,550
| – | – | 2.2% | 13 |
|
2016
Q4 | $2.09M | Buy |
72,550
+3,000
| +4% | +$86.5K | 1.93% | 15 |
|
2016
Q3 | $2.21M | Sell |
69,550
-550
| -0.8% | -$17.5K | 2.08% | 14 |
|
2016
Q2 | $2.28M | Sell |
70,100
-3,700
| -5% | -$120K | 2.23% | 13 |
|
2016
Q1 | $2.06M | Buy |
73,800
+11,400
| +18% | +$319K | 2.4% | 14 |
|
2015
Q4 | $2.23M | Buy |
62,400
+14,850
| +31% | +$530K | 2.49% | 12 |
|
2015
Q3 | $1.57M | Buy |
47,550
+7,450
| +19% | +$246K | 1.74% | 16 |
|
2015
Q2 | $1.68M | Buy |
40,100
+20,000
| +100% | +$837K | 1.64% | 18 |
|
2015
Q1 | $655K | Buy |
20,100
+8,350
| +71% | +$272K | 0.61% | 38 |
|
2014
Q4 | $373K | Sell |
11,750
-2,500
| -18% | -$79.4K | 0.34% | 64 |
|
2014
Q3 | $353K | Sell |
14,250
-200
| -1% | -$4.95K | 0.35% | 63 |
|
2014
Q2 | $326K | Buy |
14,450
+2,400
| +20% | +$54.1K | 0.3% | 73 |
|
2014
Q1 | $293K | Sell |
12,050
-100
| -0.8% | -$2.43K | 0.28% | 74 |
|
2013
Q4 | $304K | Buy |
+12,150
| New | +$304K | 0.29% | 66 |
|